We are taking steps to continue to modernize and secure our data, applications, and systems. We completed the first phase and restored many of the functions put on pause in May 2021. Now that the first phase is complete, work will resume at a slower pace but will speed up as new systems and applications are brought online. For more information and updates, please visit our Cybersecurity Modernization Initiative web page.
Battelle Laboratories – West Jefferson
(Site Profile/Docket Number 179)
Location: Columbus, Ohio
Also Known As: Battelle Columbus Laboratories (BCL), Battelle Memorial Institute (BMI), West Jefferson Plutonium Facilities
The Special Exposure Cohort (SEC) is a unique category of employees established by the Act (42 CFR Part 83). Claims compensated under the SEC do not have to go through the dose reconstruction process. To qualify for compensation under the SEC, a covered employee must meet specific requirements (e.g., must have at least one of 22 “specified cancers,” and have worked for a specified time period at one of the SEC sites). Classes of employees and work sites can be considered for addition to the SEC through a NIOSH petition process. More information about the Special Exposure Cohort can be found on our Frequently Asked Questions page.
Open/Active SEC Petitions
To date, there are no open/active SEC petitions from Battelle Laboratories – West Jefferson.
If the energy employee’s personal radiation information is incomplete, NIOSH will use other sources to estimate the radiation dose. This may involve using technical documents called Site Profiles, Technical Basis Documents, and Technical Information Bulletins.
Site Profile for Battelle Memorial Institute, King Avenue and West Jefferson Sites, Columbus, Ohio, Rev. 01 [5.6 MB (145 Pages)]
June 27, 2016
The Battelle Laboratories – King Avenue discussion papers listed below are working documents prepared by NIOSH or its contractor for use in discussions with the Advisory Board on Radiation and Worker Health or its Working Groups or Subcommittees. Draft, preliminary, interim, and white paper documents are not final NIOSH or Advisory Board (or their technical support and review contractors) positions unless specifically marked as such. These documents represent preliminary positions taken on technical issues prepared by NIOSH or its contractor.
The discussion papers have been reviewed to identify and redact any information that is protected by the Privacy Act 5 USC §552a and have been cleared for distribution.
SC&A Draft: SC&A’s Evaluation of ORAUT-OTIB-0049, Revision 02, “Estimating Doses for Plutonium Strongly Retained in the Lung” [1.3 MB (39 pages)]
Contract No. 75D30119C04183
Document No. SCA-TR-2021-PR049, Revision 0
October 7, 2021
NIOSH is committed to applying the best available science in dose reconstructions. In keeping with this commitment, completed cases with probabilities of causation less than 50% are reviewed as relevant new information becomes available. The results of these reviews are described in a Program Evaluation Report (PER). The PER details the effect, if any, of the new information on the completed dose reconstruction. If it appears that the new information may result in an increase in dose for a completed dose reconstruction with a probability of causation of less than 50%, NIOSH is committed to working with the Department of Labor to reopen and rework the dose reconstruction, as appropriate. A Program Evaluation Plan (PEP) describes plans for evaluating specific program details or issues.
About this Document: Describes the effect of revision 1 to ORAUT-OTIB-0058 (Battelle Memorial Institute) on previously completed claims.
Summary: None of the re-evaluated doses resulted in a POC greater than 50%. NIOSH will provide the Department of Labor with the list of all the claims evaluated under this PER. NIOSH will not request the return of any claims.
How to Submit Comments
Comments on Battelle Laboratories – West Jefferson Documents can be submitted to the NIOSH Docket Officer electronically by email at email@example.com or printed comments can be mailed to:
NIOSH Docket Office
Robert A. Taft Laboratories, MS-C34
1090 Tusculum Avenue
Cincinnati, OH 45226
Please include the Site Profile/Docket Number (179) on all comments.
No comments on Battelle Laboratories – West Jefferson have been received at this time.
Revision Includes: New site profile for the Battelle Memorial Institute sites in Columbus, Ohio (King Avenue) and West Jefferson, Ohio (West Jefferson). Incorporates formal internal and NIOSH review comments.